The Pharma Career Ladder · The first-line manager · Step 2: Targets, forecasts and numbers · Lesson 8

Reviewing the right doctors

By account, not by total

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

"Your territory is at plan. Good month."

That can be true, and still miss the most important thing happening in the territory.

A total is an average of many stories. A key hospital can be slipping while a few small accounts grow. The number looks fine. The problem is already there.

Pareto's principle applies here: a few accounts drive most of a territory's result. So in my monthly reviews, I start with those and not with the total.

Four things I look at with the rep:

  • The few that matter. Which doctors and accounts actually drive this territory?
  • Trend by account. Is each one growing, flat or slipping?
  • Calls versus potential. Are the highest-potential doctors the ones seen most often?
  • The next step. One agreed action for each account that is slipping.

How it is run matters as much as what is on the screen.

  • The rep brings the account view. I ask the questions.
  • We start with what is going well.
  • A slipping account is something we explore together, not a charge against the rep. Often the reason is access, stock or a competitor, not effort.
“Totals tell you how the month went. Accounts tell you why.”
Reviewing the right doctors: By account, not by total

Lesson 8 of 13 in Step 2: Targets, forecasts and numbers, with the full guide and a checklist for this week.

More lessons in step 2: Targets, forecasts and numbers

Targets, forecasts and numbers, in RepPharma

Plans approved in one click

Each rep’s monthly plan is drafted from doctor priority and visit frequency; you review and approve it in one click.

Team reviews that assemble themselves

Monthly team reviews are built from field data, and a month-end checklist shows which reps have next month’s plan, forecast and expenses in.

Forecasts graded against real sales

Bottom-up forecasts per account and product are graded against real sales every month.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.